IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Asymmetry Capital Management, L.P.

Q4 2015 Holdings

Filed 2016-02-03 | 17 holdings | $66.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
PTC Therapeutics Inc(PTCT)COM69366J200$7.7K237,10011.6%
Xenoport IncCOM98411C100$7.1K1,295,77810.8%
Quest Diagnostics Inc(DGX)COM74834L100$6.6K93,44510.1%
Acorda Therapeutics IncCOM00484M106$6.2K145,5099.4%
Centene Corp(CNC)COM15135B101$5.7K86,1398.6%
Teva Pharmaceutical(TEVA)ADR881624209$4.9K75,2867.5%
Unitedhealth Group Inc(UNH)COM91324P102$4.2K35,6866.3%
Edwards Lifesciences Corp(EW)COM28176E108$3.7K47,2305.6%
Nevro Corp(NVROEUR)COM64157F103$3.7K54,9275.6%
Alkermes PLC(ALKS)COMG01767105$2.3K29,3503.5%
Neurocrine Biosciences Inc(NBIX)COM64125C109$2.3K40,8883.5%
Impax Laboratories IncCOM45256B101$2.2K51,4303.3%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$2.1K85,8953.2%
Pacific Biosciences of Calif(PACB)COM69404D108$1.9K145,3062.9%
Amicus Therapeutics Inc(FOLD)COM03152W109$1.9K195,2062.9%
Anacor Pharmaceuticals IncCOM032420101$1.8K15,5912.7%
Synergy Pharmaceuticals IncCOM871639308$1.7K303,1572.6%